Diversified Healthcare Trust Q1 2026 Earnings: Revenue Gains Amid Persistent Headwinds
Diversified Healthcare Trust (DHC) released its first-quarter 2026 earnings results, posting a slight uptick in total revenue driven by improved performance in its senior housing portfolio. However, the company continues to grapple with inflationary pressures on labor and supply costs, which weighed on margins.
Net operating income for the quarter came in at $112 million, up 3.2% year-over-year, but missed consensus estimates by roughly 2%. Occupancy rates across the senior housing segment edged up to 82.4%, a gain of 1.1 percentage points from the prior quarter, though still below pre-pandemic levels. The medical office and life science segments remained relatively stable, with occupancy holding at 88.7%.
Management highlighted ongoing efforts to streamline operations and reduce debt, including the sale of two underperforming properties for a combined $18 million. CFO Jennifer Tran noted during the call that the company is “cautiously optimistic” about the second half of the year, citing potential benefits from moderating inflation and steady demand for senior housing as the baby boomer population ages.
Still, not all analysts are convinced. Mark Delaney, a healthcare REIT analyst at Stifel, said: “DHC is making incremental progress, but the cost structure remains a concern. Without a sharper focus on margin improvement, the stock will likely continue to trade at a discount to peers.”
More pointedly, Elena Vasquez, a portfolio manager at Horizon Capital, offered a blunt assessment: “This is a company that keeps promising a turnaround and keeps delivering mediocrity. The revenue bump is nice, but when you strip out the noise, they’re still bleeding cash in a rising rate environment. Investors deserve better.”
On a more constructive note, David Kim, a senior analyst at Green Street Advisors, said: “The occupancy recovery is real, and the demographic tailwind is undeniable. If DHC can get its cost structure under control by year-end, there’s a path to meaningful upside. The key is execution.”
Looking ahead, DHC reaffirmed its full-year 2026 normalized FFO guidance of $0.92 to $0.98 per share, but cautioned that volatility in interest rates and labor markets could pose risks. The company plans to focus on asset recycling and selective development in high-demand markets.